Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Magnus A. B. Axelsson, Naldy Parodi López, Eva Wikström Jonsson, Susanna M. Wallerstedt |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Questions in Healthcare Specifically Related to the Discipline of Pharmacy: A Descriptive Analysis of Queries to Drug Information Centres in Sweden
di: Frida Asker, et al.
Pubblicazione: (2025)
di: Frida Asker, et al.
Pubblicazione: (2025)
Hyperfiltration and Metabolism Before and After a Low‐Calorie, Pre‐Gastric Bypass Surgery Diet: Significance for Concentrations of Hydrophilic and Lipophilic Drugs
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)
Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study
di: Ahmed I. Soliman, et al.
Pubblicazione: (2025)
di: Ahmed I. Soliman, et al.
Pubblicazione: (2025)
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients
di: Kristie Rebecca Weir, et al.
Pubblicazione: (2025)
di: Kristie Rebecca Weir, et al.
Pubblicazione: (2025)
Monoclonal Antibodies During Breastfeeding—Challenges With Relative Infant Dose
di: Paulina Flis, et al.
Pubblicazione: (2025)
di: Paulina Flis, et al.
Pubblicazione: (2025)
Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)
Blood Pressure–Lowering Effects of Aldosterone Synthase Inhibitors—A Systematic Review
di: Anders Almskou Rasmussen, et al.
Pubblicazione: (2025)
di: Anders Almskou Rasmussen, et al.
Pubblicazione: (2025)
Assessing Condition‐Specific Adverse Event Profiles of Modafinil for Labelled and Off‐Label Uses: A Systematic Review and Meta‐Analysis
di: Jaehee Jung, et al.
Pubblicazione: (2025)
di: Jaehee Jung, et al.
Pubblicazione: (2025)
Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis
di: Asli Sena Kücükyildiz, et al.
Pubblicazione: (2025)
di: Asli Sena Kücükyildiz, et al.
Pubblicazione: (2025)
Long‐Term Safety and Efficacy of AAV9 Vectors Expressing Human SMN1 Gene: A Preclinical Study
di: Vahid Mansouri, et al.
Pubblicazione: (2025)
di: Vahid Mansouri, et al.
Pubblicazione: (2025)
Coumarins and Their Derivatives in Animal Models of Asthma: A Systematic Review
di: Iêda Maria dos Santos, et al.
Pubblicazione: (2026)
di: Iêda Maria dos Santos, et al.
Pubblicazione: (2026)
Review of clinical pharmacokinetics and pharmacodynamics of clonidine as an adjunct to opioids in palliative care
di: Sarwat Amna, et al.
Pubblicazione: (2024)
di: Sarwat Amna, et al.
Pubblicazione: (2024)
Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review
di: Faria Sayed, et al.
Pubblicazione: (2025)
di: Faria Sayed, et al.
Pubblicazione: (2025)
The Cardiovascular Safety of Antiparkinsonian Drugs—Analysis of Signals in the FDA Adverse Event Report System Database
di: Xin Mu, et al.
Pubblicazione: (2026)
di: Xin Mu, et al.
Pubblicazione: (2026)
The Effect of ABCB1 Polymorphisms on the Efficacy of Antidepressants
di: Sofie Voss Thorsen, et al.
Pubblicazione: (2025)
di: Sofie Voss Thorsen, et al.
Pubblicazione: (2025)
Effect of Bariatric Surgery on the Pharmacokinetics of Codeine, Oxycodone and Tramadol—A Case Series
di: Olav Spigset, et al.
Pubblicazione: (2025)
di: Olav Spigset, et al.
Pubblicazione: (2025)
Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors
di: Ruixue Li, et al.
Pubblicazione: (2024)
di: Ruixue Li, et al.
Pubblicazione: (2024)
Could Flumazenil Be Used Pre‐hospital by Intramuscular Injection for Coma due to Mixed Drug Overdose Not Responding to Naloxone?: A Systematic Review of the Evidence
di: Ilinca Farcas, et al.
Pubblicazione: (2025)
di: Ilinca Farcas, et al.
Pubblicazione: (2025)
The Incidence of Benzodiazepine and Benzodiazepine‐Related Drug Use in People With and Without Parkinson's Disease—A Nationwide Cohort Study
di: Veera Lonka, et al.
Pubblicazione: (2025)
di: Veera Lonka, et al.
Pubblicazione: (2025)
Facilitating the Implementation of Physician‐Led Medication Reviews for Patients With Severe Mental Disorder and Diabetes: A Cost‐Minimization Analysis
di: Johan Frederik Mebus Meyer Christensen, et al.
Pubblicazione: (2025)
di: Johan Frederik Mebus Meyer Christensen, et al.
Pubblicazione: (2025)
Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
di: Jamal Bousamaki, et al.
Pubblicazione: (2026)
di: Jamal Bousamaki, et al.
Pubblicazione: (2026)
Safety evaluation of adenosine, lidocaine and magnesium (ALM) intranasal therapy toward human nasal epithelial cells in vitro
di: Jodie L. Morris, et al.
Pubblicazione: (2024)
di: Jodie L. Morris, et al.
Pubblicazione: (2024)
List of Reviewers for the January 2025 Issue
Pubblicazione: (2025)
Pubblicazione: (2025)
Efficacy of weekly versus daily cholecalciferol for repleting serum vitamin D (25(OH)D) deficiency: A systematic review and meta‐analysis of randomized controlled trials
di: Émilie Bortolussi‐Courval, et al.
Pubblicazione: (2024)
di: Émilie Bortolussi‐Courval, et al.
Pubblicazione: (2024)
The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
di: Ilker Ates, et al.
Pubblicazione: (2025)
di: Ilker Ates, et al.
Pubblicazione: (2025)
Traditional Chinese Medicine in the Treatment of Infertility: A Comprehensive Review
di: Yiman Chen, et al.
Pubblicazione: (2026)
di: Yiman Chen, et al.
Pubblicazione: (2026)
The Climate Impact of Medicines in the Hospital Sector: A Scoping Review
di: Katrine Bitsch Johansen, et al.
Pubblicazione: (2026)
di: Katrine Bitsch Johansen, et al.
Pubblicazione: (2026)
Environmental Aspects in Price and Reimbursement Decisions of Medicines—A Scoping Review
di: Lasse Alajärvi, et al.
Pubblicazione: (2026)
di: Lasse Alajärvi, et al.
Pubblicazione: (2026)
Pregnancy Outcomes After Semaglutide Exposure
di: Line Kolding, et al.
Pubblicazione: (2025)
di: Line Kolding, et al.
Pubblicazione: (2025)
Review of the Delay of Chronic Kidney Disease Progression by Wuling San on Improving Renal Fibrosis
di: Zhijun Zeng, et al.
Pubblicazione: (2025)
di: Zhijun Zeng, et al.
Pubblicazione: (2025)
Development of an Artificial Intelligence Powered Medication Risk Score Calculator Application
di: Ádám Bertalan, et al.
Pubblicazione: (2025)
di: Ádám Bertalan, et al.
Pubblicazione: (2025)
Retrospective Analysis of the Use of Oral Ivermectin and 5% Permethrin Cream in Galicia (Spain)
di: S. Vazquez‐Prieto, et al.
Pubblicazione: (2025)
di: S. Vazquez‐Prieto, et al.
Pubblicazione: (2025)
Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis
di: Per‐Jostein Samuelsen, et al.
Pubblicazione: (2025)
di: Per‐Jostein Samuelsen, et al.
Pubblicazione: (2025)
Correction to ‘Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis’
Pubblicazione: (2025)
Pubblicazione: (2025)
High Throughput Pharmacovigilance Screening for Roflumilast Adverse Effects in Real‐World Settings: A Sequence Symmetry Analysis
di: Abdullah Abdelaziz, et al.
Pubblicazione: (2025)
di: Abdullah Abdelaziz, et al.
Pubblicazione: (2025)
How Is Psychotropic Use for Challenging Behaviour in People With Intellectual Disability Understood by Stakeholders? A Concept Analysis Using Rodgers' Evolutionary Approach
di: Dervla Kelly, et al.
Pubblicazione: (2025)
di: Dervla Kelly, et al.
Pubblicazione: (2025)
A Retrospective Analysis of Human Angiotensin II Receptor Blockers (ARB) Pharmacokinetics, Dosages and C max Values for the Experimental Modelling of Pleiotropic and Supratherapeutic Activities
di: Alexandria Evans, et al.
Pubblicazione: (2026)
di: Alexandria Evans, et al.
Pubblicazione: (2026)
Drug‐Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and a Real‐World Retrospective Study
di: Yanqing Song, et al.
Pubblicazione: (2025)
di: Yanqing Song, et al.
Pubblicazione: (2025)
Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs
di: Johanna K. Kujala, et al.
Pubblicazione: (2025)
di: Johanna K. Kujala, et al.
Pubblicazione: (2025)
Insights Into Gut Barrier Dysfunction and Metabolic Alterations in Mycophenolate‐Induced Enteropathy
di: Clarisse Brossier, et al.
Pubblicazione: (2026)
di: Clarisse Brossier, et al.
Pubblicazione: (2026)
Documenti analoghi
-
Questions in Healthcare Specifically Related to the Discipline of Pharmacy: A Descriptive Analysis of Queries to Drug Information Centres in Sweden
di: Frida Asker, et al.
Pubblicazione: (2025) -
Hyperfiltration and Metabolism Before and After a Low‐Calorie, Pre‐Gastric Bypass Surgery Diet: Significance for Concentrations of Hydrophilic and Lipophilic Drugs
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025) -
Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study
di: Ahmed I. Soliman, et al.
Pubblicazione: (2025) -
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients
di: Kristie Rebecca Weir, et al.
Pubblicazione: (2025) -
Monoclonal Antibodies During Breastfeeding—Challenges With Relative Infant Dose
di: Paulina Flis, et al.
Pubblicazione: (2025)